Germ cell mutagens: Risk assessment challenges in the 21st century

Environmental and Molecular Mutagenesis

Volumn 51, Issue 8-9, 2010, Pages 919-928

  Singer, Timothy M ^a   Yauk, Carole L ^a  

^a HEALTH CANADA   (Canada)

Author keywords

Heritable mutation; Mutagenicity tests; Risk assessment

Indexed keywords

CHEMICAL MUTAGEN; ENVIRONMENTAL MUTAGEN; INDUSTRIAL CHEMICAL; MUTAGENIC AGENT;

CANCER PREVENTION; CARCINOGENESIS; CHILDHOOD CANCER; DNA METHYLATION; DNA MICROARRAY; DNA STRAND BREAKAGE; ENVIRONMENTAL EXPOSURE; EPIGENETICS; GENE CONTROL; GENE EXPRESSION; GENE SEQUENCE; GENETIC RISK; GENETIC SCREENING; GENETIC VARIABILITY; GENOMICS; GENOTOXICITY; GERM CELL; HIGH THROUGHPUT SCREENING; HUMAN; IN VITRO STUDY; MUTAGENESIS; MUTATION RATE; NONHUMAN; NUCLEOTIDE SEQUENCE; REVIEW; RISK ASSESSMENT; SOMATIC CELL; TANDEM REPEAT; TOXICITY TESTING; X CHROMOSOME; GENETICS; HISTORY; MUTAGEN TESTING; MUTATION;

ANIMALIA;

GERM-LINE MUTATION; HISTORY, 21ST CENTURY; HUMANS; MUTAGENICITY TESTS; MUTAGENS; RISK ASSESSMENT;

EID: 78349237711     PISSN: 08936692     EISSN: 10982280     Source Type: Journal    
DOI: 10.1002/em.20613     Document Type: Review

References (89)

1. Adler ID, Ashby J. 1989. The present lack of evidence for unique rodent germ-cell mutagens. Mutat Res 212: 55-66.
2. Ames BN. 1973. Carcinogens are mutagens: Their detection and classification. Environ Health Perspect 6: 115-118.
3. Ames BN, Durston WE, Yamasaki E, Lee FD. 1973a. Carcinogens are mutagens: A simple test system combining liver homogenates for activation and bacteria for detection. Proc Natl Acad Sci USA 70: 2281-2285.
4. Ames BN, Lee FD, Durston WE. 1973b. An improved bacterial test system for the detection and classification of mutagens and carcinogens. Proc Natl Acad Sci USA 70: 782-786.
5. Anway MD, Cupp AS, Uzumcu M, Skinner MK. 2005. Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science 308: 1466-1469.
6. Armour JA. 2006. Tandemly repeated DNA: Why should anyone care? Mutat Res 598: 6-14.
7. Ashby J, Tinwell H. 2001. Continuing ability of the rodent bone marrow micronucleus assay to act as a predictor of the possible germ cell mutagenicity of chemicals. Mutat Res 478: 211-213.
8. Baccarelli A, Bollati V. 2009. Epigenetics and environmental chemicals. Curr Opin Pediatr 21: 243-251.
9. Barber RC, Hickenbotham P, Hatch T, Kelly D, Topchiy N, Almeida GM, Jones GD, Johnson GE, Parry JM, Rothkamm K. 2006. Radiation-induced transgenerational alterations in genome stability and DNA damage. Oncogene 25: 7336-7342.
10. Baumgartner A, Cemeli E, Anderson D. 2009. The comet assay in male reproductive toxicology. Cell Biol Toxicol 25: 81-98.
11. Bochukova EG, Huang N, Keogh J, Henning E, Purmann C, Blaszczyk K, Saeed S, Hamilton-Shield J, Clayton-Smith J, O'Rahilly S, Hurles ME, Farooqi IS. 2010. Large, rare chromosomal deletions associated with severe early-onset obesity. Nature 463: 666-670.
12. Brinster RL. 2007. Male germline stem cells: From mice to men. Science 316: 404-405.
13. Chang JS, Selvin S, Metayer C, Crouse V, Golembesky A, Buffler PA. 2006. Parental smoking and the risk of childhood leukemia. Am J Epidemiol 163: 1091-1100.
14. Cheung HH, Lee TL, Rennert OM, Chan WY. 2009. DNA methylation of cancer genome. Birth Defects Res C Embryo Today 87: 335-350.
15. Conrad DF, Pinto D, Redon R, Feuk L, Gokcumen O, Zhang Y, Aerts J, Andrews TD, Barnes C, Campbell P. 2010. Origins and functional impact of copy number variation in the human genome. Nature 464: 704-712.
16. Cordier S, Lefeuvre B, Filippini G, Peris-Bonet R, Farinotti M, Lovicu G, Mandereau L. 1997. Parental occupation, occupational exposure to solvents and polycyclic aromatic hydrocarbons and risk of childhood brain tumors (Italy, France, Spain). Cancer Causes Control 8: 688-697.
17. Cordier S, Monfort C, Filippini G, Preston-Martin S, Lubin F, Mueller BA, Holly EA, Peris-Bonet R, McCredie M, Choi W. 2004. Parental exposure to polycyclic aromatic hydrocarbons and the risk of childhood brain tumors: The SEARCH International Childhood Brain Tumor Study. Am J Epidemiol 159: 1109-1116.
18. Csaba G, Inczefi-Gonda A. 1998. Transgenerational effect of a single neonatal benzpyrene treatment on the glucocorticoid receptor of the rat thymus. Hum Exp Toxicol 17: 88-92.
19. De Grassi A, Ciccarelli FD. 2009. Tandem repeats modify the structure of human genes hosted in segmental duplications. Genome Biol 10: R137.
20. Dearfield KL, Douglas GR, Ehling UH, Moore MM, Sega GA, Brusick DJ. 1995. Acrylamide: A review of its genotoxicity and an assessment of heritable genetic risk. Mutat Res 330: 71-99.
21. DeMarini DM. 2004. Genotoxicity of tobacco smoke and tobacco smoke condensate: A review. Mutat Res 567: 447-474.
22. Department of National Health and Welfare, Canada. 1993. The assessment of mutagenicity. Health Protection Branch Mutagenicity Guidelines. Environ Mol Mutagen 21: 15-37.
23. Dubrova YE, Nesterov VN, Krouchinsky NG, Ostapenko VA, Neumann R, Neil DL, Jeffreys AJ. 1996. Human minisatellite mutation rate after the Chernobyl accident. Nature 380: 683-686.
24. Dubrova YE, Nesterov VN, Krouchinsky NG, Ostapenko VA, Vergnaud G, Giraudeau F, Buard J, Jeffreys AJ. 1997. Further evidence for elevated human minisatellite mutation rate in Belarus eight years after the Chernobyl accident. Mutat Res 381: 267-278.
25. Dubrova YE, Plumb M, Brown J, Fennelly J, Bois P, Goodhead D, Jeffreys AJ. 1998. Stage specificity, dose response, and doubling dose for mouse minisatellite germ-line mutation induced by acute radiation. Proc Natl Acad Sci USA 95: 6251-6255.
26. Dubrova YE, Bersimbaev RI, Djansugurova LB, Tankimanova MK, Mamyrbaeva Z, Mustonen R, Lindholm C, Hulten M, Salomaa S. 2002a. Nuclear weapons tests and human germline mutation rate. Science 295: 1037.
27. Dubrova YE, Grant G, Chumak AA, Stezhka VA, Karakasian AN. 2002b. Elevated minisatellite mutation rate in the post-Chernobyl families from Ukraine. Am J Hum Genet 71: 801-809.
28. Dubrova YE, Ploshchanskaya OG, Kozionova OS, Akleyev AV. 2006. Minisatellite germline mutation rate in the Techa River population. Mutat Res 602: 74-82.
29. Eastmond DA, Hartwig A, Anderson D, Anwar WA, Cimino MC, Dobrev I, Douglas GR, Nohmi T, Phillips DH, Vickers C. 2009. Mutagenicity testing for chemical risk assessment: Update of the WHO/IPCS Harmonized Scheme. Mutagenesis 24: 341-349.
30. European Chemicals Agency. 2008. Guidance on information requirements and chemical safety assessment, Chapter R. 7a: Endpoint specific guidance. Available at:
31. European Commission. 2008. Report on the Development, Validation and Legal Acceptance of Alternative Methods to Animal Tests in the Field of Cosmetics (2007). Brussels, Belgium: Commission of the European Communities.
32. Favor J, Layton D, Sega G, Wassom J, Burkhart J, Douglas G, Dearfield K, Brusick D. 1995. International commission for protection against environmental mutagens and carcinogens. Genetic risk extrapolation from animal data to human disease. A Taskgroup Report No 00105. Mutat Res 330: 23-34.
33. Filkowski J, Ilnytskyy Y, Tamminga J, Koturbash I, Golubov A, Bagnyukova T, Pogribny I, Kovalchuk O. 2010. Hypomethylation and genome instability in the germline of exposed parents and their progeny is associated with altered miRNA expression. Carcinogenesis 31: 1110-1115.
34. Fujiwara S, Suyama A, Cologne JB, Akahoshi M, Yamada M, Suzuki G, Koyama K, Takahashi N, Kasagi E, Grant EJ. 2008. Prevalence of adult-onset multifactorial disease among offspring of atomic bomb survivors. Radiat Res 170: 451-457.
35. Gilad Y, Pritchard JK, Thornton K. 2009. Characterizing natural variation using next-generation sequencing technologies. Trends Genet 25: 463-471.
36. Glen CD, Smith AG, Dubrova YE. 2008. Single-molecule PCR analysis of germ line mutation induction by anticancer drugs in mice. Cancer Res 68: 3630-3636.
37. Gu W, Zhang F, Lupski JR. 2008. Mechanisms for human genomic rearrangements. Pathogenetics 1: 4
38. Hales BF, Crosman K, Robaire B. 1992. Increased postimplantation loss and malformations among the F2 progeny of male rats chronically treated with cyclophosphamide. Teratology 45: 671-678.
39. Hardwick RJ, Tretyakov MV, Dubrova YE. 2009. Age-related accumulation of mutations supports a replication-dependent mechanism of spontaneous mutation at tandem repeat DNA loci in mice. Mol Biol Evol 26: 2647-2654.
40. Holden HE. 1982. Comparison of somatic and germ cell models for cytogenetic screening. J Appl Toxicol 2: 196-200.
41. Ji BT, Shu XO, Linet MS, Zheng W, Wacholder S, Gao YT, Ying DM, Jin F. 1997. Paternal cigarette smoking and the risk of childhood cancer among offspring of nonsmoking mothers. J Natl Cancer Inst 89: 238-244.
42. Korlach J, Bibillo A, Wegener J, Peluso P, Pham TT, Park I, Clark S, Otto GA, Turner SW. 2008. Long, processive enzymatic DNA synthesis using 100% dye-labeled terminal phosphate-linked nucleotides. Nucleosides Nucleotides Nucleic Acids 27: 1072-1083.
43. Lambert IB, Singer TM, Boucher SE, Douglas GR. 2005. Detailed review of transgenic rodent mutation assays. Mutat Res 590: 1-280.
44. La Salle S, Sun F, Handel MA. 2009. Isolation and short-term culture of mouse spermatocytes for analysis of meiosis. Methods Mol Biol 558: 279-297.
45. Lee KM, Ward MH, Han S, Ahn HS, Kang HJ, Choi HS, Shin HY, Koo HH, Seo JJ, Choi JE. 2009. Paternal smoking, genetic polymorphisms in CYP1A1 and childhood leukemia risk. Leuk Res 33: 250-258.
46. Madanat-Harjuoja LM, Malila N, Lahteenmaki P, Pukkala E, Mulvihill JJ, Boice JDJr, Sankila R. 2010. Risk of cancer among children of cancer patients: A nationwide study in Finland. Int J Cancer 126: 1196-1205.
47. Maltaris T, Beckmann MW, Dittrich R. 2009. Review. Fertility preservation for young female cancer patients. In Vivo 23: 123-130.
48. McCann J, Choi E, Yamasaki E, Ames BN. 1975. Detection of carcinogens as mutagens in the Salmonella/microsome test: Assay of 300 chemicals. Proc Natl Acad Sci USA 72: 5135-5139.
49. McCarroll SA, Huett A, Kuballa P, Chilewski SD, Landry A, Goyette P, Zody MC, Hall JL, Brant SR, Cho JH, Duerr RH, Silverberg MS, Taylor KD, Rioux JD, Altshuler D, Daly MJ, Xavier RJ. 2008. Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease. Nat Genet 40: 1107-1112.
50. Meissner A, Mikkelsen TS, Gu H, Wernig M, Hanna J, Sivachenko A, Zhang X, Bernstein BE, Nusbaum C, Jaffe DB, Gnirke A, Jaenisch R, Lander ES. 2008. Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 454: 766-770.
51. Metzker ML. 2010. Sequencing technologies-The next generation. Nat Rev Genet 11: 31-46.
52. Mirkin SM. 2007. Expandable DNA repeats and human disease. Nature 447: 932-940.
53. Narod SA, Douglas GR, Nestmann ER, Blakey DH. 1988. Human mutagens: Evidence from paternal exposure? Environ Mol Mutagen 11: 401-415.
54. National Research Council. 2007. Toxicity Testing in the 21st Century: A Vision and a Strategy. Washington, DC: National Academies Press.
55. National Toxicology Program. 2004. A National Toxicology Program for the 21st Century: A Roadmap for the Future. Research Triangle Park, NC: National Toxicology Program, National Institute of Environmental Health Sciences.
56. Newbold RR, Padilla-Banks E, Jefferson WN. 2006. Adverse effects of the model environmental estrogen diethylstilbestrol are transmitted to subsequent generations. Endocrinology 147 ( 6 Suppl): S11-S17.
57. Ossowski S, Schneeberger K, Lucas-Lledo JI, Warthmann N, Clark RM, Shaw RG, Weigel D, Lynch M. 2010. The rate and molecular spectrum of spontaneous mutations in Arabidopsis thaliana. Science 327: 92-94.
58. Pang D, McNally R, Birch JM. 2003. Parental smoking and childhood cancer: Results from the United Kingdom Childhood Cancer Study. Br J Cancer 88: 373-381.
59. Pleasance ED, Stephens PJ, O'Meara S, McBride DJ, Meynert A, Jones D, Lin ML, Beare D, Lau KW, Greenman C. 2010a. A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 463: 184-190.
60. Pleasance ED, Cheetham RK, Stephens PJ, McBride DJ, Humphray SJ, Greenman CD, Varela I, Lin ML, Ordonez GR, Bignell GR. 2010b. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 463: 191-196.
61. Reik W. 2007. Stability and flexibility of epigenetic gene regulation in mammalian development. Nature 447: 425-432.
62. Rhomberg L, Dellarco VL, Siegel-Scott C, Dearfield KL, Jacobson-Kram D. 1990. Quantitative estimation of the genetic risk associated with the induction of heritable translocations at low-dose exposure: Ethylene oxide as an example. Environ Mol Mutagen 16: 104-125.
63. Rovida C, Hartung T. 2009. Re-evaluation of animal numbers and costs for in vivo tests to accomplish REACH legislation requirements for chemicals-A report by the transatlantic think tank for toxicology (t(4)). ALTEX 26: 187-208.
64. Russell LB, Selby PB, von Halle E, Sheridan W, Valcovic L. 1981. The mouse specific-locus test with agents other than radiations: Interpretation of data and recommendations for future work. Mutat Res 86: 329-354.
65. Russell LB. 2004. Effects of male germ-cell stage on the frequency, nature, and spectrum of induced specific-locus mutations in the mouse. Genetica 122: 25-36.
66. Sebat J, Lakshmi B, Malhotra D, Troge J, Lese-Martin C, Walsh T, Yamrom B, Yoon S, Krasnitz A, Kendall J. 2007. Strong association of de novo copy number mutations with autism. Science 316: 445-449.
67. Secretan B, Straif K, Baan R, Grosse Y, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L. 2009. A review of human carcinogens-Part E: Tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol 10: 1033-1034.
68. Shah SP, Morin RD, Khattra J, Prentice L, Pugh T, Burleigh A, Delaney A, Gelmon K, Guliany R, Senz J. 2009. Mutational evolution in a lobular breast tumor profiled at single nucleotide resolution. Nature 461: 809-813.
69. Shelby MD, Bishop JB, Mason JM, Tindall KR. 1993. Fertility, reproduction, and genetic disease: Studies on the mutagenic effects of environmental agents on mammalian germ cells. Environ Health Perspect 100: 283-291.
70. Shlien A, Malkin D. 2009. Copy number variations and cancer. Genome Med 1: 62.
71. Siristatidis CS, Maheshwari A, Bhattacharya S. 2009. In vitro maturation in sub fertile women with polycystic ovarian syndrome undergoing assisted reproduction. Cochrane Database Syst Rev 1: CD006606.
72. Stephens PJ, McBride DJ, Lin ML, Varela I, Pleasance ED, Simpson JT, Stebbings LA, Leroy C, Edkins S, Mudie LJ. 2009. Complex landscapes of somatic rearrangement in human breast cancer genomes. Nature 462: 1005-1010.
73. Stukenborg JB, Schlatt S, Simoni M, Yeung CH, Elhija MA, Luetjens CM, Huleihel M, Wistuba J. 2009. New horizons for in vitro spermatogenesis? An update on novel three-dimensional culture systems as tools for meiotic and post-meiotic differentiation of testicular germ cells. Mol Hum Reprod 15: 521-529.
74. Tam GW, Redon R, Carter NP, Grant SG. 2009. The role of DNA copy number variation in schizophrenia. Biol Psychiatry 66: 1005-1012.
75. Tinwell H, Brinkworth MH, Ashby J. 2001. Further evidence for the rodent bone marrow micronucleus assay acting as a sensitive predictor of the possible germ cell mutagenicity of chemicals. Mutat Res 473: 259-261.
76. U.S. EPA. 1986. Environmental Protection Agency: Guidelines for mutagenicity risk assessment. Fed Regist 51: 34006-34012.
77. Verstrepen KJ, Jansen A, Lewitter F, Fink GR. 2005. Intragenic tandem repeats generate functional variability. Nat Genet 37: 986-990.
78. Vilariño-Güell C, Smith AG, Dubrova YE. 2003. Germline mutation induction at mouse repeat DNA loci by chemical mutagens. Mutat Res 526: 63-73.
79. Waters MD, Stack HF, Jackson MA, Bridges BA. 1993. Hazard identification: Efficiency of short-term tests in identifying germ cell mutagens and putative nongenotoxic carcinogens. Environ Health Perspect 101 ( Suppl 3): 61-72.
80. Waters MD, Stack HF, Jackson MA, Bridges BA, Adler ID. 1994. The performance of short-term tests in identifying potential germ cell mutagens: A qualitative and quantitative analysis. Mutat Res 341: 109-131.
81. Witt KL, Hughes LA, Burka LT, McFee AF, Mathews JM, Black SL, Bishop JB. 2003. Mouse bone marrow micronucleus test results do not predict the germ cell mutagenicity of N-hydroxymethylacrylamide in the mouse dominant lethal assay. Environ Mol Mutagen 41: 111-120.
82. Wyrobek AJ, Mulvihill JJ, Wassom JS, Malling HV, Shelby MD, Lewis SE, Witt KL, Preston RJ, Perreault SD, Allen JW, Demarini DM, Woychik RP, Bishop JB. 2007. Assessing human germ-cell mutagenesis in the Postgenome Era: A celebration of the legacy of William Lawson (Bill) Russell. Environ Mol Mutagen 48: 71-95.
83. Yauk C, Polyzos A, Rowan-Carroll A, Somers CM, Godschalk RW, Van Schooten FJ, Berndt ML, Pogribny IP, Koturbash I, Williams A. 2008. Germ-line mutations, DNA damage, and global hypermethylation in mice exposed to particulate air pollution in an urban/industrial location. Proc Natl Acad Sci USA 105: 605-610.
84. Yauk CL. 2004. Advances in the application of germline tandem repeat instability for in situ monitoring. Mutat Res 566: 169-182.
85. Yauk CL, Dubrova YE, Grant GR, Jeffreys AJ. 2002. A novel single molecule analysis of spontaneous and radiation-induced mutation at a mouse tandem repeat locus. Mutat Res 500: 147-156.
86. Yauk CL, Berndt ML, Williams A, Rowan-Carroll A, Douglas GR, Stampfli MR. 2007. Mainstream tobacco smoke causes paternal germ-line DNA mutation. Cancer Res 67: 5103-5106.
87. Yeh JR, Zhang X, Nagano MC. 2007. Establishment of a short-term in vitro assay for mouse spermatogonial stem cells. Biol Reprod 77: 897-904.
88. Zhang F, Gu W, Hurles ME, Lupski JR. 2009. Copy number variation in human health, disease, and evolution. Annu Rev Genom Hum Genet 10: 451-481.
89. Zilberman D, Coleman-Derr D, Ballinger T, Henikoff S. 2008. Histone H2A.Z and DNA methylation are mutually antagonistic chromatin marks. Nature 456: 125-129.